Microbial flora in patients with bronchopulmonary pathology
DOI:
https://doi.org/10.5281/zenodo.17923418Keywords:
бронхоплевральні захворювання, мікробна флора, антибактеріальна терапія., bronchopleural diseases, microbial flora, antibacterial therapy.Abstract
Introduction. The study of microbial pathogens of acute purulent-destructive diseases of the lungs and pleura significantly affects the further course of the disease and the outcome of treatment. The appointment of antibacterial drugs taking into account the sensitivity to the microbial pathogen has a significant advantage compared to broad-spectrum antibacterial therapy. Materials and methods. The results of microbiological studies of tracheobronchial tree and pleural cavity washes in 500 patients with bronchopulmonary pathology for the period 2008-2024 were analyzed. This section of the study was completed by patients who made up the control (238 patients (47.6%) and the main group (262 patients (52.4%) of the study. Results and Discussion. This study provided an idea of the significance of the spectrum of microbial flora of bronchial and pleural washes in patients with bronchopulmonary pathology during different periods of its complex treatment. Conclusions. Studies of microbial flora in patients with bronchopleural diseases reflect specific pathological pathways and can become an important tool for making clinical decisions when managing this complex cohort of patients.
References
Stjärne Aspelund A, Hammarström H, Inghammar M, Larsson H, Hansson L, Riise GC, Friman V, Christensson B, Påhlman LI. Microbiological findings in bronchoalveolar lavage fluid from lung transplant patients in Sweden. Transpl Infect Dis. 2018;20(6):e12973. doi:10.1111/tid.12973.
Hassan M, Cargill T, Harriss E, et al. The microbiology of pleural infection in adults: a systematic review. Eur Respir J. 2019;54(3):1900542. doi:10.1183/13993003.00542-2019.
Franchetti L, Schumann DM, Tamm M, Jahn K, Stolz D. Multiplex bacterial polymerase chain reaction in a cohort of patients with pleural effusion. BMC Infect Dis. 2020;20:99. doi:10.1186/s12879-020-4793-6.
Chan KPF, Ma TF, Sridhar S, Lam DCL, Ip MSM, Ho PL. Changes in Etiology and Clinical Outcomes of Pleural Empyema during the COVID-19 Pandemic. Microorganisms. 2023;11(2):303. doi:10.3390/microorganisms11020303.
Mukae H, Noguchi S, Yatera K, et al. The importance of obligate anaerobes and the Streptococcus anginosus group in pulmonary abscess: a clone library analysis using bronchoalveolar lavage fluid. Respiration. 2016;92(2):80–90. doi:10.1159/000447976.
Park CK, Oh HJ, Choi HY, Shin HJ, Lim JH, Oh IJ, Kim YI, Lim SC, Kim YC, Kwon YS. Microbiological characteristics and predictive factors for mortality in pleural infection: a single-center cohort study in Korea. PLoS One. 2016;11(8):e0161280. doi:10.1371/journal.pone.0161280.
Yovi I, Safari D, Syah NA, Anggraini D, Hanifah ZN, Shapira VZ, Elliyanti AB. Bacterial Profile and Antimicrobial Resistance Patterns of Pleural Empyema in Pekanbaru Hospitals. J Respir Indo. 2024;44(1):36–44. doi:10.36497/jri.v44i1.590.
Takahashi S, Ishitsuka T, Namatame K, Nakamura M. A false-positive pneumococcal rapid urinary antigen test in Streptococcus intermedius infection. Respirol Case Rep. 2019;7(7):e00466. doi:10.1002/rcr2.466.
Iyer NP, Reddy CB, Wahidi MM, et al. Indwelling pleural catheter versus pleurodesis for malignant pleural effusions: systematic review and meta-analysis. Ann Am Thorac Soc. 2019;16:124–131. doi:10.1513/AnnalsATS.201807-495OC.
Chaddha U, Agrawal A, Feller-Kopman D, et al. Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: consensus statement. Lancet Respir Med. 2021;9(9):1050–1064. doi:10.1016/S2213-2600(20)30533-6.
Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society Guideline for pleural disease. Thorax. 2023;78(Suppl 3):s1–s42. doi:10.1136/thorax-2022-219784.
Sziklavari Z, Graml JI, Zeman F, et al. Outcomes of Stage-Adapted Surgical Treatment of Pleural Empyema. Zentralbl Chir. 2016;141(3):335–340. doi:10.1055/s-0041-109703.
Porcel JM. Minimally invasive treatment of complicated parapneumonic effusions and empyemas in adults. Clin Respir J. 2018;12(4):1361–1366. doi:10.1111/crj.12730.
Boyko VV, Lopatenko DE. Pathogenic flora in pyopneumothorax and its sensitivity to antibiotics. Kharkiv Surgical School. 2013;4(61):54–56.
Seder CW, Raymond D, Wright CD, et al. The Society of Thoracic Surgeons General Thoracic Surgery Database 2018 Update. Ann Thorac Surg. 2018;105(5):1304–1307. doi:10.1016/j.athoracsur.2018.02.006.
Sziklavari Z, Riedb M, Neub R, et al. Mini-open vacuum-assisted closure therapy with instillation for debilitated and septic patients with pleural empyema. Eur J Cardiothorac Surg. 2015;48:9–16. doi:10.1093/ejcts/ezv186.
Chen RL, Zhang YQ, Wang J, et al. Diagnostic value of medical thoracoscopy for undiagnosed pleural effusions. Exp Ther Med. 2018;16(6):4590–4594. doi:10.3892/etm.2018.6742.
Díez-Delhoyo F, Gutiérrez-Ibañes E, Sanz-Ruiz R, et al. Prevalence of microvascular and endothelial dysfunction. Circ Cardiovasc Interv. 2019;12(2):e007257. doi:10.1161/CIRCINTERVENTIONS.118.007257.
Psallidas I, Piotrowska HEG, Yousuf A, et al. Efficacy of sonographic and biological pleurodesis indicators (SIMPLE). BMJ Open Respir Res. 2017;4(1):e000225. doi:10.1136/bmjresp-2017-000225.
Prevots DR, et al. Nontuberculous mycobacterial pulmonary disease: increasing burden. Eur Respir J. 2017;49(4):1700374. doi:10.1183/13993003.00374-2017.
Shojaee S, Lee HJ. Thoracoscopy: medical versus surgical. J Thorac Dis. 2015;7(4):339–351. doi:10.3978/j.issn.2072-1439.2015.11.66.
Walker S, Maskell N. Identification and management of pleural effusions of multiple aetiologies. Curr Opin Pulm Med. 2017;23(4):339–345. doi:10.1097/MCP.0000000000000388.
Hajjar WM, Ahmed I, Al-Nassar SA. Video-assisted thoracoscopic decortication in late stage empyema. Ann Thorac Med. 2016;11(1):71–78. doi:10.4103/1817-1737.165293.
Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16(2):101–133. doi:10.1214/ss/1009213286.
Bedawi EO, Hassan M, Rahman NM, et al. ERS/ESTS statement on the management of pleural infection. Eur Respir J. 2023;61(2):2201062. Available from: https://publications.ersnet.org/content/erj/61/2/2201062
British Thoracic Society. Management of pleural infection in adults (2010 guideline). Thorax. 2010;65(Suppl 2):ii41–ii53. Available from: https://files.sld.cu/renacip/files/2014/12/pleural-infection-bts-2010-pleural-infection.pdf
Brook I. Microbiology and management of empyema and thoracic abscesses. Curr Opin Pulm Med. 2019;25(3):261–269. Available from: https://pubmed.ncbi.nlm.nih.gov/30753188/
Mukae H, Noguchi S, Yatera K, et al. Obligate anaerobes in pulmonary abscess. Respiration. 2016;92(2):80–90. (дубль, але якщо у вас в статті двічі — лишаю). Available from: https://karger.com/res/article/92/2/80/294791
Clinical and Laboratory Standards Institute. QC of microbiological transport systems. CLSI M40-A2. 2014. Available from: https://clsi.org/standards/products/microbiology/documents/m40/
CLSI. Principles and Procedures for Detection of Anaerobes. CLSI M56-A. 2014. Available from: https://clsi.org/standards/products/microbiology/documents/m56/
Baron EJ, Finegold SM. Bailey & Scott’s Diagnostic Microbiology. 13th ed. Mosby; 2014. Available from: https://www.sciencedirect.com/book/9780323083300/bailey-and-scotts-diagnostic-microbiology
CLSI. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. CLSI M11. 2018. Available from: https://clsi.org/standards/products/microbiology/documents/m11/
CLSI. Performance Standards for Antimicrobial Susceptibility Testing; M100. 2022. Available from: https://clsi.org/standards/products/microbiology/documents/m100/
EUCAST. Disk Diffusion Method and Quality Control. Available from: https://www.eucast.org/bacteria/methodology-and-instructions/disk-diffusion-and-quality-control/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Annals of Mechnikov's Institute
This work is licensed under a Creative Commons Attribution 4.0 International License.
